More patients are tested and treated for osteoporosis when fracture clinics have someone dedicated to screening for the bone disease, a new study has found.
Those patients also do better when the clinic actually provides bone mineral density (BMD) testing or prescription drug treatment as part of its program rather than just referring fracture patients elsewhere.
Researchers at St. Michael's Hospital led by Joanna Sale, a clinical epidemiologist, reviewed osteoporosis screening and management programs involving patients treated for fragility fractures by orthopedic staff in 11 countries.
The study, published in the journal Osteoporosis International, was unusual in that it examined both randomized trials and clinical programs available to all patients.
"We found that patient outcomes were better with programs that had dedicated personnel to test for and treat the disease," said Sale, an associate scientist in the hospital's Mobility Program Clinical Research Unit.
"A fracture clinic is a very busy place. Patients are in pain. You have orthopedic surgeons, residents, physiotherapists, orthopedic technicians. It makes sense to have someone who can identify patients who might have osteoporosis, educate them, refer them for a bone mineral density test, schedule them for the test and write a prescription.
"Outcomes are also better when the test or treatment takes place within the program, rather than sending the patient elsewhere and potentially losing contact with them."
Sale said the review had some challenges with comparing data across studies. Some programs reported statistics based on all patients, others based only on patients who went for bone density tests and still others based on bone density scores. An important consideration for future research is the need to standardize reporting, she said.
Osteoporosis is a disease characterized by low bone mass and deterioration of bone tissue. This leads to increased bone fragility and risk of fracture, particularly of the hip, spine and wrist. Many people are not aware they have osteoporosis until they suffer a fracture and are tested for the condition.
As many as 2 million Canadians suffer from osteoporosis, including one in four women over the age of 50. Osteoporosis Canada estimates it costs $1.9 billion a year to treat the disease and the fractures it causes, with most of the money going to long-term, hospital and chronic care. Given the increasing proportion of older people in the population, these costs will likely rise.
St. Michael's was perhaps the first hospital in Ontario to screen and educate all patients over 50 with a fragility fracture (suffered in a fall from standing height or less, such as slipping n ice) for osteoporosis and send them for a BMD test. The program, led by Dr. Earl Bogoch and Victoria Elliot-Gibson, runs out of the fracture clinic.
The Ministry of Health and Long-Term Care has initiated a similar program in 36 other fracture clinics across the province as part of the Ontario Osteoporosis Strategy. A team at St. Michael's led by Dr. Bogoch and Dr. Dorcas Beaton is leading the evaluation of this program and researching ways to make post-fracture care better.
About St. Michael's Hospital
St. Michael's Hospital provides compassionate care to all who enter its doors. The hospital also provides outstanding medical education to future health care professionals in more than 23 academic disciplines. Critical care and trauma, heart disease, neurosurgery, diabetes, cancer care, and care of the homeless are among the Hospital's recognized areas of expertise. Through the Keenan Research Centre and the Li Ka Shing International Healthcare Education Center, which make up the Li Ka Shing Knowledge Institute, research and education at St. Michael's Hospital are recognized and make an impact around the world. Founded in 1892, the hospital is fully affiliated with the University of Toronto.
For more information please contact:Leslie Shepherd
Leslie Shepherd | EurekAlert!
Multi-year study finds 'hotspots' of ammonia over world's major agricultural areas
17.03.2017 | University of Maryland
Diabetes Drug May Improve Bone Fat-induced Defects of Fracture Healing
17.03.2017 | Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke
Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.
The results will be published on March 22 in the journal „Astronomy & Astrophysics“.
Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...
Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.
Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...
In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...
20.03.2017 | Event News
14.03.2017 | Event News
07.03.2017 | Event News
24.03.2017 | Materials Sciences
24.03.2017 | Physics and Astronomy
24.03.2017 | Physics and Astronomy